Skip to main content
. 2012 Jul 13;7:3679–3688. doi: 10.2147/IJN.S32853

Table 2.

IC50 of DXR solution, F–PLL- and PLL-coated liposomal DXR against KB cells or A549 cells at 48 hours

Formulation IC50 (μM)

KB cells A549 cells
DXR solution 1.20 2.17
F–PLL-coated liposomal DXR 30.75 104.31
PLL-coated liposomal DXR 64.97 105.71

Abbreviations: DXR, doxorubicin; F-PLL, folate-poly(L-lysine).